Horizon Quantum Holdings Ltd. ("Horizon Quantum"), a pioneer of software infrastructure for quantum applications, today ...
(Reuters) - Horizon Pharma Inc (NMQ:HZNP) said it would buy Dublin-based Vidara Therapeutics International Ltd in a reverse merger for $660 million (£397.09 million), the latest U.S. company looking ...
Another day, another biopharma expansion on the Emerald Isle: Following a spate of Irish pharma growth this summer, Horizon Therapeutics is getting in on the action. Horizon has submitted a planning ...
In a bid to take advantage of low tax rates in Ireland, Horizon Pharma (NASDAQ:HZNP) unveiled plans on Wednesday to acquire Irish specialty drug maker Vidara in a $660 million cash-and-stock reverse ...
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced $140,000 in scholarships to help economically disadvantaged students from Trinity College Dublin and Waterford ...
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced it submitted a planning application to expand its development and manufacturing facility in Waterford, Ireland to add ...
DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: NZNP) today announced that it has been recognized as one of the 2020 Best Workplaces in Ireland, ranking 13th in the small company category.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results